Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Curasan AG       DE0005494538

CURASAN AG

No quotes available
-- EUR   0.00%
09/12CURASAN : New CEO at curasan AG
PU
09/12CURASAN : Torben Sorensen new CEO at curasan AG
PU
09/12CURASAN : Torben Sorensen new CEO at curasan AG
EQ
SummaryNewsCalendarCompany 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Sector news Biopharmaceuticals
12:58pNOVARTIS : Sandoz Halting Ranitidine Distribution
DJ
11:52aNOVARTIS : halts distribution of its Zantac versions amid probe into impurities
RE
11:41aALEXION PHARMACEUTICALS : Shares Fall Following CFO Change
DJ
10:21aALLERGAN : Form 8.3 - Allergan Plc
DJ
08:08aBIOGEN : to Study Higher Dose of Spinraza in Spinal Muscular Atrophy
DJ
06:26aROCHE : Genentech Gets FDA Breakthrough Designation for Gazyva in Lupus Nephriti..
DJ
06:06aChina's Henlius raises $410 million in Hong Kong IPO - sources
RE
02:32aAstraZeneca Amends China Collaboration Agreement With Ironwood
DJ
09/17ALEXION PHARMACEUTICALS : Names New Finance Chief
DJ
09/17ABBVIE : Form 8.3 - Allergan Plc
DJ
09/17BAYER : Invests $20 Million in U.S.-Based Informed Data Systems
DJ
09/17Merck Gets FDA Priority Review for Investigational Ebola Zaire Virus Vaccine
DJ
09/17Trial of Tepco executives over Japan's Fukushima disaster heads to conclusion
RE
09/17NOVARTIS : CHF0.50(REGD) Novartis Cosentyx(R) -2-
DJ
09/17NOVARTIS : CHF0.50(REGD) Novartis Cosentyx(R) Positive 16-week Prevent Results A..
DJ
09/16ALLERGAN : Form 8.3 - Allergan Plc
DJ
09/16ASTRAZENECA : FDA Grants Fast Track Designation for Farxiga in Heart Failure
DJ
09/16JOHNSON & JOHNSON : J&J's Janssen Seeks FDA OK of Tremfya in Active Psoriatic Ar..
DJ
09/16H LUNDBECK : Lundbeck buys Alder in $2 billion migraine treatment move
RE
09/16A Plan to Fight Hep C -- WSJ
DJ
09/16SANOFI : Abbott to Collaborate on Glucose Sensing, Insulin Delivery Data
DJ
09/14NOVARTIS : Trial and Error -2-
DJ
09/14NOVARTIS : Trial and Error
DJ
09/13NOVARTIS : The Startup That Manipulated Data to Get a -2-
DJ
09/13NOVARTIS : The Startup That Manipulated Data to Get a Miracle Drug to Market
DJ
09/13SANOFI : FDA Finds Probable Carcinogen in Some Versions of Zantac --Update
DJ
09/13SANOFI : FDA Finds Probable Carcinogen in Some Versions of Zantac --Update
DJ
09/13Correction to Opioid Reckoning Hits Money Managers
DJ
09/13SANOFI : FDA Finds Probable Carcinogen in Some Versions of Zantac
DJ
09/13ALLERGAN : Form 8.3 - Allergan Plc
DJ
09/13AMGEN : Phase 3 Study of Kyprolis, Darzalex Meets Primary Endpoint
DJ
09/13DISCOVER FINANCIAL SERVICES : Names Greene as Financial Chief
DJ
09/13Opioid Reckoning Hits Money Managers
DJ
09/13Biopharmaceutical Company Imara Inc. Files Confidentially for IPO
DJ
09/12PFIZER : SpringWorks Therapeutics IPO Prices at High End of Range
DJ
09/12GLAXOSMITHKLINE : FDA Approves GlaxoSmithKline's Nucala For Children Ages 6-11 W..
DJ
09/12ALLERGAN : Form 8.3 -
DJ
09/12ABBVIE : Form 8.3 -
DJ
09/12SpringWorks Raises IPO to 9 Million Shares at $16-$18 Each
DJ
09/11AURORA CANNABIS : pushes back profitability target to fiscal 2020
RE
09/11Swiss Biotech Anokion Raises $40 Million in Series B Round
DJ
09/11UPDATE : Form 8.3 - Allergan Plc (Correction of Doc)
DJ
09/11MERCK : Gets FDA Breakthrough-Therapy Designation for Tepotinib
DJ
09/11SANOFI : India Plans to Sell Pharmaceutical Manufacturing Site in India to Zenti..
DJ
09/11MERCK : Backs 2019 View; Sees Profitable Growth Over Next Years
DJ
09/10Henlius Biotech launches $477 million HK IPO, testing market amid protests
RE
09/10LEXICON PHARMACEUTICALS : Sanofi to pay Lexicon $260 million for terminated part..
RE
09/10LEXICON PHARMACEUTICALS : Says It Terminated Sanofi Alliance
DJ
09/10BAYER : to reduce size of management board to five
RE
09/10Merck Down Nearly 5%, on Pace for Largest Percent Decrease Since October 2017..
DJ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on CURASAN AG